Abnormality in sheep chromosome 16p, 13.11?
At 8 months into the pregnancy, due to certain reasons, an amniocentesis was performed, which revealed a 0.64mb deletion at 16p13.11.
Both parents' blood tests showed no issues.
I have searched some literature and would like to ask the physician for recommendations regarding this situation.
lilianna, 30~39 year old female. Ask Date: 2023/04/24
Dr. Jian Yingxiu reply Rare Disease
Please bring the relevant reports to the genetic counseling clinic for your appointment.
Reply Date: 2023/04/24
More Info
The discovery of a 0.64 Mb deletion at the 16p13.11 locus during your amniocentesis can understandably raise concerns about potential implications for your baby's health. This specific chromosomal deletion has been associated with a range of developmental and behavioral issues, although the exact outcomes can vary significantly from case to case.
Understanding 16p13.11 Deletion
The 16p13.11 region is known to harbor several genes that are crucial for normal development. Deletions in this area can lead to various phenotypic manifestations, including developmental delays, intellectual disabilities, and behavioral problems. However, it is important to note that the clinical presentation can be highly variable, and not all individuals with this deletion will exhibit noticeable symptoms.
Clinical Implications
1. Incomplete Penetrance: One of the key aspects of genetic deletions like the one at 16p13.11 is the concept of incomplete penetrance. This means that even if a deletion is present, it does not guarantee that the individual will exhibit any clinical symptoms. Some individuals may be asymptomatic, while others may experience significant challenges.
2. Associated Conditions: Research has indicated that deletions in the 16p13.11 region can be linked to conditions such as autism spectrum disorders, attention-deficit/hyperactivity disorder (ADHD), and other neurodevelopmental disorders. However, the presence of the deletion alone does not predict the severity or type of disorder that may arise.
3. Risk Assessment: The risk of developmental issues associated with 16p13.11 deletions has been estimated to be around 10-20%, but this can vary based on the specific genes affected and the size of the deletion. In your case, the 0.64 Mb deletion may encompass several genes, and further genetic counseling can help clarify the potential risks.
Recommendations
1. Genetic Counseling: It is highly advisable to consult with a genetic counselor who can provide personalized insights based on your specific situation. They can help interpret the results of the deletion in the context of your family history and any other relevant factors.
2. Detailed Ultrasound: A detailed ultrasound examination can help assess the fetal anatomy and identify any potential structural abnormalities that may be associated with the deletion. This can provide additional information about the baby's health.
3. Monitoring and Support: If your baby is born with the deletion, early intervention services can be beneficial. These services can include physical therapy, speech therapy, and educational support, tailored to the child's specific needs.
4. Stay Informed: Continue to seek out reputable sources of information regarding 16p13.11 deletions. Academic journals and genetic databases can provide insights into the latest research findings and case studies related to this specific deletion.
5. Emotional Support: It is natural to feel anxious about the implications of genetic findings. Consider seeking support from family, friends, or support groups for parents facing similar challenges. Sharing experiences can provide comfort and understanding.
Conclusion
While the discovery of a 0.64 Mb deletion at 16p13.11 can be concerning, it is essential to approach the situation with a balanced perspective. Many individuals with similar deletions lead healthy lives, and with appropriate support and monitoring, your child can thrive. Engaging with healthcare professionals, particularly genetic counselors, will be crucial in navigating this journey and making informed decisions for your family's future.
Similar Q&A
Impact of Chromosome 16p13.11 Deletion on Fetal Development and Screening
Hello, this amniotic fluid chip has confirmed a primary mutation. I would like to ask if there are any case numbers in Taiwan that can be referenced regarding the impact of this deletion on the fetus? The mention of an expressivity rate of 13.1%—is that considered high? If the co...
Dr. Jian Yingxiu reply Rare Disease
The 16p13.11 microdeletion is currently known to potentially cause developmental delays, learning disabilities, or epilepsy; however, there are also reports of asymptomatic cases. Therefore, it is not a condition with a 100% penetrance. Additionally, since the range and size of t...[Read More] Impact of Chromosome 16p13.11 Deletion on Fetal Development and Screening
Understanding the Impact of Chromosome 15q11.2 Microdeletions on Rare Diseases
The deletion at 138275 is located at the long arm of chromosome 15, specifically at q11.2, within the region from 22,770,421 to 23,282,798, which corresponds to OMIM (615656). What potential impacts could this have? The blood test has confirmed it is hereditary, but the mother is...
Dr. Chen Ming reply Rare Disease
Please scan your report and send it to [email protected]. Additionally, call 04-7238595 ext. 7244 to request assistance from a genetic counselor to add me to the Chang Gung Memorial Hospital outpatient clinic. God bless you. [The case results do not specify the genome version...[Read More] Understanding the Impact of Chromosome 15q11.2 Microdeletions on Rare Diseases
Understanding 16p13.3 Microduplication: Implications for Fetal Health
Hello Doctor, I am a 30-year-old first-time mother who is 20 weeks pregnant. I have Graves' disease, which is well-controlled with medication. I have had intermittent mild microcytic anemia in the past, and my doctor has suspected either thalassemia or iron deficiency anemia...
Dr. Jian Yingxiu reply Rare Disease
Hello: Anticipating new life yet encountering such uncertainty can indeed be unsettling. It seems you have already gathered all the information, but due to incomplete penetrance, even if one parent has similar chromosomal variations, there is still a chance that the baby may expe...[Read More] Understanding 16p13.3 Microduplication: Implications for Fetal Health
Understanding 22q11.2 Deletion: Clinical Insights and Genetic Testing Options
Hello Dr. Jian, due to the newborn screening for Severe Combined Immunodeficiency (SCID), my child did not pass the first two tests, but the third test has shown normal values, and additional tests indicate that the immune function is within normal range. However, the 22q11.2 chr...
Dr. Jian Yingxiu reply Rare Disease
22q11.2 deletion is known in the literature to be one of the causes of abnormal SCID screening results. Babies with this condition may have normal SCID screening values, slightly low values that normalize upon follow-up, or persistently abnormal values. If a 22q11.2 deletion has ...[Read More] Understanding 22q11.2 Deletion: Clinical Insights and Genetic Testing Options
Related FAQ
(Rare Disease)
Chromosomes(Rare Disease)
G6Pd Deficiency(Rare Disease)
Congenital Metabolic Disorders(Rare Disease)
Disease Name(Rare Disease)
Neurology(Rare Disease)
Osteogenesis Imperfecta(Rare Disease)
Height(Rare Disease)
Newborn Screening(Rare Disease)
Hair(Rare Disease)